Recombinant tissue-type plasminogen activator.
Collen
D
D
Bennett
W F
WF
D000595:Amino Acid Sequence; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004341:Drug Evaluation; D005342:Fibrinolysis; D005796:Genes; D006801:Humans; D008545:Melanoma / Q000201:enzymology / Q000473:pathology; D008969:Molecular Sequence Data; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D009363:Neoplasm Proteins / Q000302:isolation & purification / Q000627:therapeutic use; D011817:Rabbits; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000493:pharmacokinetics / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000302:isolation & purification / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000201:enzymology
D009363:Neoplasm Proteins; D011993:Recombinant Fusion Proteins; D013300:Streptokinase; D010959:Tissue Plasminogen Activator